Large Joint Pain Drops

Generic Name: large joint pain drops

Over-the-Counter (OTC)

Brand Names:

Large Joint Pain Drops 2037

*Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.

Overview

*Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.

Uses

INDICATIONS For the temporary relief of minor joint pain or inflammation, particularly in the knees, ankles, lower back, elbows, or shoulders.*

Dosage

DIRECTIONS Place drops under tongue 30 minutes before/after meals. Adults and children 12 years and over: Take 10 drops up to 3 times per day for up to 6 weeks. For immediate onset of symptoms, take 10 to 15 drops every 15 minutes up to 3 hours. For less severe symptoms, take 10-15 drops hourly up to 8 hours. Consult a physician for use in children under 12 years of age.

Warnings

WARNINGS In case of overdose, get medical help or contact a poison control center right away. Keep out of the reach of children. If pregnant or breastfeeding, ask a healthcare professional before use.

Pregnancy

If pregnant or breastfeeding, ask a healthcare professional before use.

Frequently Asked Questions

What is Large Joint Pain Drops used for?▼

INDICATIONS For the temporary relief of minor joint pain or inflammation, particularly in the knees, ankles, lower back, elbows, or shoulders.*

Can I take Large Joint Pain Drops during pregnancy?▼

If pregnant or breastfeeding, ask a healthcare professional before use.

What are the important warnings for Large Joint Pain Drops?▼

Related Medications

Abatacept

abatacept

Selective T Cell Costimulation Modulator [EPC]

11 DESCRIPTION Abatacept is a selective T-cell costimulation modulator. Abatacept is a soluble fusion protein that consists of the extracellular domain of human cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4) linked to the modified Fc (hinge, CH2, and CH3 domains) portion of human immunoglobulin G1 (IgG1). Abatacept is produced by recombinant DNA technology in a mammalian cell expression system. The apparent molecular weight of abatacept is 92 kilodaltons.

Lidocaine Hcl, Phenylephrine Hcl, Witch Hazel

lidocaine hcl, phenylephrine hcl, witch hazel

Anorectal; anesthetic, vasoconstrictor, astringent

Brinzolamide

brinzolamide

Carbonic Anhydrase Inhibitor [EPC]

11 DESCRIPTION Brinzolamide ophthalmic suspension, USP 1% contains a carbonic anhydrase inhibitor formulated for multidose topical ophthalmic use. Brinzolamide is described chemically as: (R)-(+)-4-Ethylamino-2-(3-methoxypropyl)-3,4-dihydro-2H-thieno [3,2-e]-1,2-thiazine-6-sulfonamide-1,1- dioxide. Its empirical formula is C 12 H 21 N 3 O 5 S 3 , and its structural formula is: Brinzolamide has a molecular weight of 383.5 g/mol and a melting point of about 131°C.

Medical Disclaimer

This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.